BridgeMD
New treatment option for High Blood Sugar
Official title Effect of ANKASCIN 568-P Products on Decreasing HbA1c and Regulating Blood Glucose
ClinicalTrials.gov ID: NCT05737342
What this study is testing
- What it's testing
- This study is a randomized, double-blind, placebo-controlled, parallel-controlled trial (24 weeks in total), divided into three periods (screening, treatment, and discontinuation follow-up)
- You might receive a placebo (an inactive treatment) instead of the study drug, decided by chance. You may not know which one you got.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Men or non-pregnant women over 20 years old (women of childbearing age are not allowed to become pregnant or breastfeed during the study) adults who...
- 18≦BMI≦35.
- Blood routine examination (CBC; Complete blood count): the mean corpuscular volume MCV should not be less than 70 fL.
- Blood glucose level measurement meets any of the following conditions: (1) The fasting blood sugar is between 100∼125 mg/dL, and the doctor judges...
You likely can't join if
- Blood pressure: systolic blood pressure ≧ 200 mmHg or diastolic blood pressure ≧ 140 mmHg.
- Moderate or severe liver and kidney dysfunction (generally refers to serum aminopyruvate converting enzyme (SGPT) and serum glutamate phenylacetate...
- Pregnant or lactating women.
- Diabetic patients taking hypoglycemic drugs or insulin injections.
- Those who take traditional Chinese medicine mainly red yeast rice.
- Have undergone surgery within one month.
See the full eligibility criteria
- Men or non-pregnant women over 20 years old (women of childbearing age are not allowed to become pregnant or breastfeed during the study) adults who are sane and able to communicate.
- 18≦BMI≦35.
- Blood routine examination (CBC; Complete blood count): the mean corpuscular volume MCV should not be less than 70 fL.
- Blood glucose level measurement meets any of the following conditions: (1) The fasting blood sugar is between 100∼125 mg/dL, and the doctor judges that there is no need to use hypoglycemic drugs for the time being. (2)...
- Blood pressure: systolic blood pressure ≧ 200 mmHg or diastolic blood pressure ≧ 140 mmHg.
- Moderate or severe liver and kidney dysfunction (generally refers to serum aminopyruvate converting enzyme (SGPT) and serum glutamate phenylacetate transaminase (SGOT) are more than 3 times higher than the upper limit...
- Pregnant or lactating women.
- Diabetic patients taking hypoglycemic drugs or insulin injections.
- Those who take traditional Chinese medicine mainly red yeast rice.
- Have undergone surgery within one month.
- Combined with serious diseases such as heart, liver, kidney and hematopoietic system, mentally ill patients who do not meet the inclusion criteria, who do not eat the test samples according to the regulations, so that...
The study team makes the final eligibility decision.
Where it's taking place
- Taipei, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taipei, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.